Understanding self-mutilation in borderline personality disorder

Harvard Review of Psychiatry

Volumn 13, Issue 3, 2005, Pages 179-185

  Paris, Joel ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Borderline personality disorder; Self mutilation

Indexed keywords

ENDORPHIN; MOOD STABILIZER; NALTREXONE; NEUROLEPTIC AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

AFFECT; AUTOMUTILATION; BEHAVIOR THERAPY; BORDERLINE STATE; CLINICAL ARTICLE; COGNITIVE THERAPY; COPING BEHAVIOR; DISTRESS SYNDROME; EMOTION; HUMAN; IMPULSIVENESS; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; RISK; SUICIDE ATTEMPT;

BORDERLINE PERSONALITY DISORDER; HUMANS; SELF-INJURIOUS BEHAVIOR; SUICIDE, ATTEMPTED;

EID: 22044434257     PISSN: 10673229     EISSN: None     Source Type: Journal    
DOI: 10.1080/10673220591003614     Document Type: Review

References (104)

1. Gerson J, Stanley B. Suicidal and self-injurious behavior in personality disorder: controversies and treatment directions. Curr Psychiatry Rep 2002;4:30-8.
2. Favazza AR. The coming of age of self-mutilation. J Nerv Ment Dis 1998;186:259-68.
3. Osuch EA, Noll JG, Putnam FW. The motivations for self-injury in psychiatric inpatients. Psychiatry 1999;62:334-46.
4. Schroeder SR, Oster-Granite M-L, Thompson T, eds. Self-injurious behavior: gene-brain-behavior relationships. Washington, DC: American Psychological Association, 2002.
5. Klonsky ED, Oltmanns TF, Turkheimer E. Deliberate self-harm in a nonclinical population: prevalence and psychological correlates. Am J Psychiatry 2003;160:1501-8.
6. Haw C, Hawton K, Houston K, Townsend E. Psychiatric and personality disorders in deliberate self-harm patients. Br J Psychiatry 2001;178:48-54.
7. Comtois KA. A review of interventions to reduce the prevalence of parasuicide. Psychiatr Serv 2002;53:1138-44.
8. Asch SS. Wrist scratching as a symptom of anhedonia. Psychoanal Q 1967;40:630-7.
9. Graff H, Mallin R. The syndrome of the wrist cutter. Am J Psychiatry 1967;124:36-42.
10. Gruenbaum H, Herman GL. Wrist slashing. Am J Psychiatry 1967;124:527-34.
11. Pao NP. The syndrome of deliberate self-cutting. Brit J Med Psychol 1967;42:195-206.
12. Rosenthal RJ, Rinzler C, Walsh R, Klausner E. Wrist-cutting syndrome. Am J Psychiatry 1972;128:1363-8.
13. Pattison EM, Kahan J. The deliberate self-harm syndrome. Am J Psychiatry 1983;140:867-72.
14. Walsh BW, Rosen P. Self-mutilation: theory, research, and practice. New York: Guilford, 1988.
15. Winchel RM, Stanley M. Self-injurious behavior: a review of the behavior and biology of self-mutilation. Am J Psychiatry 1991;148:306-17.
16. Herpertz S. Self-injurious behaviour. Psychopathological and nosological characteristics in subtypes of self-injurers. Acta Psychiatr Scand 1995;91:57-68.
17. Favazza AR, Favazza B. Bodies under siege: self-mutilation in culture and psychiatry, Baltimore, MD: Johns Hopkins University Press, 1988.
18. Favazza AR. Why patients mutilate themselves. Hosp Community Psychiatry 1989;40:137-45.
19. Zoroglu SS, Tuzun U, Sar V, et al. Suicide attempt and self-mutilation among Turkish high school students in relation with abuse, neglect and dissociation. Psychiatry Clin Neurosci 2003;57:119-26.
20. Mohino JS, Ortega-Monasterio L, Planchat-Teruel LM, Cuquerella-Fuentes A, Talon-Navarro T, Macho-Vives LJ. Discriminating deliberate self-harm (DSH) in young prison inmates through personality disorder. J Forensic Sci 2004;49:137-40.
21. Stanley B, Gameroff MJ, Michalsen V, Mann JJ. Are suicide attempters who self-mutilate a unique population? Am J Psychiatry 2001;158:427-32.
22. Brown MZ, Comtois KA, Linehan MM. Reasons for suicide attempts and nonsuicidal self-injury in women with borderline personality disorder. J Abnorm Psychol 2002;111:198-202.
23. Sabo AN, Gunderson JG, Najavits LM, Chauncey D, Kisiel C. Changes in self-destructiveness of borderline patients in psychotherapy. A prospective follow-up. J Nerv Ment Dis 1995;183:370-6.
24. Paris J. Implications of long-term outcome research for the management of patients with borderline personality disorder. Harv Rev Psychiatry 2002;10:315-23.
25. Hawton K, Zahl D, Weatherall R. Suicide following deliberate self harm: long-term follow-up of patients who presented to a general hospital. Br J Psychiatry 2003;182:537-42.
26. Gunderson JG, Ridolfi ME. Borderline personality disorder: suicidality and self-mutilation. Ann N Y Acad Sci 2001;932:61-73.
27. Gunderson JG. Borderline personality disorder: a clinical guide. Washington, DC: American Psychiatric Press, 2001.
28. Linehan MM. Dialectical behavioral therapy of borderline personality disorder. New York: Guilford, 1993.
29. Crawley JN, Sutton ME, Pickar D. Animal models of self destructive behavior and suicide. Psychiatr Clin N Am 1985;8:299-310.
30. Paris J. Half in love with easeful death: the meaning of chronic suicidality in borderline personality disorder. Harv Rev Psychiatry 2004;12:42-8.
31. Paris J. Chronic suicidality in borderline personality disorder. Psychiatr Serv 2002;53:738-42.
32. Dubo ED, Zanarini MC, Lewis RE, Williams AA. Childhood antecedents of self-destructiveness in borderline personality disorder. Can J Psychiatry 1997;42:63-9.
33. Shearer SL. Phenomenology of self-injury among inpatient women with borderline personality disorder. J Nerv Ment Dis 1994;182:524-6.
34. van der Kolk BA, Hostetler A, Herren N, Fisler RE. Trauma and the development of borderline personality disorder. Psychiatr Clin N Am 1994;17:715-30.
35. Leibenluft E, Gardner DL, Cowdry RW. The inner experience of the borderline self-mutilator. J Personal Disord 1987;1:317-24.
36. Zweig-Frank H, Paris J, Guzder J. Psychological risk factors for disssociation and self-mutilation in female patients with personality disorders. Can J Psychiatry 1994;39:259-65.
37. Zlotnick C, Mattia JI, Zimmerman M. Clinical correlates of self-mutilation in a sample of general psychiatric patients. J Nerv Mental Dis 1999;187:296-301.
38. Russ MJ, Clark WC, Cross LW, Kemperman I, Kakuma T, Harrison K. Pain and self-injury in borderline patients: sensory decision theory, coping strategies, and locus of control. Psychiatry Res 1996;63:57-65.
39. Russ MJ, Campbell SS, Kakuma T, Harrison K. Zanine E. EEG theta activity and pain insensitivity in self-injurious borderline patients. Psychiatry Res 1999;89:201-14.
40. Kemperman I, Russ MJ, Clark WC, Kakuma T, Zanine E, Harrison K. Pain assessment in self-injurious patients with borderline personality disorder using signal detection theory. Psychiatry Res 1997;70:175-83.
41. Kemperman I, Russ MJ, Shearin E. Self-injurious behavior and mood regulation in borderline patients. J Personal Disord 1997;11:146-57.
42. Bohus M, Limberger M, Ebner U, et al. Pain perception during self-reported distress and calmness in patients with borderline personality disorder and self-mutilating behavior. Psychiatry Res 2000;95:251-60.
43. Simeon D, Stanley B, Frances A, Mann JJ, Winchel R, Stanley M. Self-mutilation in personality disorders: psychological and biological correlates. Am J Psychiatry 1992;149:221-6.
44. Dulit RA, Fyer MR, Leon AC, Brodsky BS, Frances AJ. Clinical correlates of self-mutilation in borderline personality disorder. Am J Psychiatry 1994;151:1305-11.
45. Herpertz S, Sass H, Favazza A. Impulsivity in self-mutilative behavior: psychometric and biological findings. J Psychiatr Res 1997;31:451-65.
46. Goodman M, New A. Impulsive aggression in borderline personality disorder. Curr Psychiatry Rep 2000;2:56-61.
47. Siever LJ, Davis KL. A psychobiological perspective on the personality disorders. Am J Psychiatry 1991;148:1647-58.
48. Koenisgberg HW, Harvey PD, Mitropolou V, et al. Characterizing affective instability in borderline personality disorder. Am J Psychiatry 2002;159:784-8.
49. Bruce KR, Steiger H, Koerner NM, Israel M, Young SN. Bulimia nervosa with co-morbid avoidant personality disorder: behavioural characteristics and serotonergic function. Psychol Med 2004;34:113-24.
50. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. Am J Psychiatry 2001;158:1783-93.
51. Links PS, Heslegrave R, van Reekum R. Impulsivity: core aspect of borderline personality disorder. J Personal Disord 1999;13:131-9.
52. Gardner DL, Cowdry RW. Suicidal and parasuicidal behavior in borderline personality disorder. Psychiatr Clin N Am 1985;8:389-403.
53. Seroczynski AD, Bergeman CS, Coccaro EF. Etiology of the impulsivity/aggression relationship: genes or environment? Psychiatry Res 1999;86:41-57.
54. Oquendo MA, Mann JJ. The biology of impulsivity and suicidality. Psychiatr Clin N Am 2002;23:11-25.
55. Coccaro EF, Siever LJ, Klar HM, et al. Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry 1989;46:587-99.
56. Jang KL, Livesley WJ, Vernon PA, Jackson DN. Heritability of personality traits: a twin study. Acta Psychiatr Scand 1996;94:438-44.
57. Zweig-Frank H, Paris J, Guzder J. Psychological risk factors for dissociation in female patients with borderline and non-borderline personality disorders. J Personal Disord 1994;8:203-9.
58. Brodsky BS, Cloitre M, Dulit RA. Relationship of dissociation to self-mutilation and childhood abuse in borderline personality disorder. Am J Psychiat 1995;152:1788-92.
59. Fossati A, Madeddu F, Maffei C. Borderline personality disorder and childhood sexual abuse: a meta-analytic study. J Personal Disord 1999;13:268-80.
60. Brodsky BS, Oquendo M, Ellis SP, Haas GL, Malone KM, Mann JJ. The relationship of childhood abuse to impulsivity and suicidal behavior in adults with major depression. Am J Psychiatry 2001;158:1871-7.
61. Goodman M, Weiss DS, Koenigsberg H, et al. The role of childhood trauma in differences in affective instability in those with personality disorders. CNS Spectr 2003;8:763-70.
62. Livesley WJ, Jang KL, Vernon PA. Phenotypic and genetic structure of traits delineating personality disorder. Arch Gen Psychiatry 1998;55:941-8.
63. Taiminen TJ, Kallio-Soukainen K, Nokso-Koivisto H, Kaljonen A, Helenius H. Contagion of deliberate self-harm among adolescent inpatients. J Am Acad Child Adolesc Psychiatry 1998;37:211-7.
64. Levy DA, Nail PR. Contagion, a theoretical and empirical review and reconceptualization. Genet Soc Gen Psychol Monogr 1993;119:233-84.
65. Crandall CS. Social contagion of binge eating. J Pers Soc Psychol 1988;55:588-98.
66. Hull JW, Yeomans F, Clarkin J, Li C, Goodman G. Factors associated with multiple hospitalizations of patients with borderline personality disorder. Psychiatr Serv 1996;47:638-41.
67. Paris J. Is hospitalization useful for suicidal patients with borderline personality disorder? J Personal Disord 2004;18:240-7.
68. Koerner K, Linehan MM. Research on dialectical behavior therapy for patients with borderline personality disorder. Psychiatr Clin N Am 2000;23:151-67.
69. Bohus M, Haaf B, Stiglmayr C, Pohl U, Bohme R, Linehan M. Evaluation of inpatient dialectical-behavioral therapy for borderline personality disorder-a prospective study. Behav Res Ther 2000;38:875-87.
70. Verheul R, Van Den Bosch LM, Koeter MW, De Ridder MA, Stijnen T, Van Den Brink W. Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomized clinical trial in The Netherlands. Br J Psychiatry 2003;182:135-40.
71. Young JE. Cognitive therapy for personality disorders: a schema-focused approach. 3rd ed. Sarasota, FL: Professional Resource, 1999.
72. Kern RS, Kuehnel TG, Teuber J, Hayden JL. Multimodal cognitive-behavior therapy for borderline personality disorder with self-injurious behavior. Psychiatr Serv 1997;48:1131-3.
73. Tyrer P, Thompson S, Schmidt U, et al. Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med 2003;33:969-76.
74. Perry JC, Banon E, Ianni F. Effectiveness of psychotherapy for personality disorders. Am J Psychiatry 1999;156:1312-21.
75. Leichsenring, F, Leibing, E. The effectiveness of psychodynamic therapy and cognitive behavior therapy in the treatment of personality disorders: a meta-analysis. Am J Psychiatry 2003;160:1223-32.
76. Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry 1999;156:1563-9.
77. Bateman A, Fonagy P. Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. Am J Psychiatry 2001;158:36-42.
78. Bateman A, Fonagy P. Psychotherapy for borderline personality disorder: mentalization-based treatment. Oxford: Oxford University Press, 2004.
79. Fonagy P. An update on BPD treatment evaluation research in England. Presented to the NIMH International Think Tank for the More Effective Treatment of Borderline Personality Disorder, Lincthinum, MD, July 2004.
80. Linehan, MM. The application of dialectical behavior therapy (DBT) to chronic suicidality in borderline personality disorder. Presented to the International Society for the Study of Personality Disorders, Florence. Italy, October 2003.
81. Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 1993;50:377-85.
82. Chengappa KN, Ebeling T, Kang JS, Levine J, Parepally H. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. J Clin Psychiatry 1999;60:477-84.
83. Hough DW. Low-dose olanzapine for self-mutilation behavior in patients with borderline personality disorder. J Clin Psychiatry 2001;62:296-7.
84. Zanarini MC, Frankenburg FR. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 2001;62:849-54.
85. Markovitz PJ, Calabrese JR, Schulz SC, Meltzer HY. Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am J Psychiatry 1991;148:1064-7.
86. Rinne T, van den Brink W, Wouters L, van Dyck R. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry 2002;159: 2048-54.
87. Gardner DL, Cowdry RW. Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder. Am J Psychiatry 1986;143:519-22.
88. Pinto O, Akiskal H. Lamotrigine as a promising approach to borderline personality. J Affect Disord 1998;51:333-43.
89. Hollander E, Allen A, Lopez RP, et al. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J Clin Psychiatry 2001;62:199-203.
90. Frankenburg FR, Zanarini MC. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 2002;63:442-6.
91. Roth AS, Ostroff RB, Hoffman RE. Naltrexone as a treatment for repetitive self-injurious behaviour: an open-label trial. J Clin Psychiatry 1996;57:233-7.
92. Soloff P. Psychopharmacological treatment of borderline personality disorder. Psychiatr Clin N Am 2000;23:169-92.
93. Paris J. Personality disorders over time. Washington, DC: American Psychiatric Press, 2003.
94. Livesley WJ. The practical management of personality disorder. New York: Guilford, 2003.
95. Rockland LH. A supportive approach: psychodynamically oriented supportive therapy of borderline patients who self-mutilate. J Personal Disord 1987;1:350-5.
96. Garner DM. Cognitive therapy for bulimia nervosa. Adolesc Psychiatry 1986;13:358-90.
97. Ciccheti D, Rogosch FA. A developmental psychopathology perspective on adolescence. J Consult Clin Psychol 2002;70:6-20.
98. Paris J, Zweig-Frank H. A 27-year follow-up of borderline patients. Compr Psychiatry 2001;42:482-7.
99. Stone MH. The fate of borderline patients. New York: Guilford, 1990.
100. Zanarini MC, Frankenburg FR, Hennen J, Silk KR. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. Am J Psychiatry 2003;160:274-83.
101. Links PS, Heslegrave R, van Reekum R. Prospective follow-up study of borderline personality disorder: prognosis, prediction of outcome, and Axis II comorbidity. Can J Psychiatry 1998;43:265-70.
102. McGlashan TH. The Chestnut Lodge follow-up study III: long-term outcome of borderline personalities. Arch Gen Psychiatry 1986;43:2-30.
103. Gunderson JG, Bender D, Sanislow C, et al. Plausibility and possible determinants of sudden "remissions" in borderline patients. Psychiatry 2003;66:111-9.
104. McGlashan TH. Implications of outcome research for the treatment of borderline personality disorder. In Paris J, ed. Borderline personality disorder: etiology and treatment. Washington. DC: American Psychiatric Press, 1993:235-60.